SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-19-010193
Filing Date
2019-05-08
Accepted
2019-05-08 19:42:16
Documents
2
Period of Report
2019-04-18

Document Format Files

Seq Description Document Type Size
1 FORM 3/A doc1.html 3/A  
1 FORM 3/A doc1.xml 3/A 1804
2 poa_karbe.htm EX-24 9027
  Complete submission text file 0001567619-19-010193.txt   12252
Mailing Address C/O ARBUTUS BIOPHARMA CORP. 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
KARBE FRANK (Reporting) CIK: 0001276700 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37345 | Film No.: 19808361

Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Issuer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations